Currently, the most widely used vaccine against TB is the Bacillus Calmette-Guérin (BCG). Developed in 1921, the vaccine ...

The platform can be harnessed for TB, potentially improving protection and durability of immunity in a way that traditional ...

COVID-19 vaccines target emerging variants, offering improved protection. Learn about their effectiveness, timing, and safety ...

An update from AIM Vaccine Co., Ltd. Class H ( ($HK:6660) ) is now available. AIM Vaccine Co., Ltd. announced the strategic integration of ...

As public skepticism toward mRNA vaccines grows, lawmakers in several states are taking decisive action to protect their constituents from what they deem potential risks associated with these ...